tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Tom Smith, 92 are a BUY (100%).
Analyst Tom Smith, currently employed at LEERINK, carries an average stock price target met ratio of 100% that have a potential upside of 0.05% achieved within 9 days.
Tom Smith’s has documented 3 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KROS, Keros Therapeutics at 08-Dec-2020.
Analyst best performing recommendations are on KROS (KEROS THERAPEUTICS ).
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$25
$10.79 (75.93%)
$43
23 days ago
(09-Apr-2025)
0/6 (0%)
$14.67 (142.01%)
Buy
$40
$25.79 (181.49%)
$40
1 months 1 days ago
(01-Apr-2025)
1/13 (7.69%)
$30.45 (318.85%)
113
Buy
$26
$11.79 (82.97%)
$111
2 months 5 days ago
(27-Feb-2025)
1/3 (33.33%)
$15.06 (137.66%)
74
Buy
$15
$0.79 (5.56%)
$105
3 months 15 days ago
(17-Jan-2025)
5/12 (41.67%)
$4.14 (38.12%)
43
Hold
3 months 15 days ago
(17-Jan-2025)
0/1 (0%)
$41.46 (76.02%)
What Year was the first public recommendation made by Tom Smith?
